A 90-year-old former jewelry shop assistant was the first to get a shot, followed, appropriately enough, by a man named William Shakespeare.
Tag: Pfizer Inc
Here’s Why Vaccinated People Still Need to Wear a Mask
The new vaccines will probably prevent you from getting sick with Covid. No one knows yet whether they will keep you from spreading the virus to others — but that information is coming.
U.K. Covid Vaccine: Side Effects, Safety, and Who Gets It First
The mass inoculation campaign that began in Britain on Tuesday has little precedent in modern medicine.
U.K. Tackles Giant Vaccine Rollout After Botched Covid Response
Britain left hospitals short of masks and gowns, and stumbled on testing and tracing, so can it vaccinate tens of millions of people in a matter of months? Experts think it can.
For Boris Johnson, Vaccine Rollout Offers Last Chance to Show Competence
With the vaccine rollout and a potential Brexit deal looming, his government has a chance to wash away its reputation for chaos and mismanagement.
U.K. and U.S. Officials Spar Over Coronavirus ‘Vaccine Nationalism’
Scientists warned that a debate over which country’s regulatory system is better could undermine public faith in vaccines. Meanwhile, Britons waited to learn how soon they can get coronavirus shots.
The UK Just Approved the Pfizer Covid Vaccine. What Happens Next?
When early results from the final trials began to roll in, scientists were well prepared. Now, they face the logistical challenge of putting the vaccine to work.
U.K. Approves Pfizer Coronavirus Vaccine, a First in the West
The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.
How the Out-of-Control Pandemic Is Speeding the Testing of Vaccines
The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective
Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public.